Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package

Total article views   HTML views PDF downloads Totals
11,006 Dovepress* 9,795+ 2,078 11,873
PubMed Central* 1,211 418 1,629
Totals 11,006 2,496 13,502
*Since 6 December 2012
+Since July 2016

View citations on PubMed Central and Google Scholar